News No Increase Seen in OD Deaths Involving Buprenorphine During COVID-19 Publish Date January 24, 2023
Drugs in the Pipeline Intranasal Nalmefene Gets Priority Review for Opioid Overdose Treatment By Brian Park, PharmD Publish Date January 20, 2023
Drugs in the Pipeline December 2022 Recap: Drug Pipeline Updates By Brian Park, PharmD Publish Date January 11, 2023
Drugs in the Pipeline RiVive Nasal Spray Gets Priority Review for OTC Treatment of Opioid Overdose By Brian Park, PharmD Publish Date December 27, 2022
Drugs in the Pipeline Narcan Nasal Spray Gets Priority Review for OTC Treatment of Opioid Overdose By Brian Park, PharmD Publish Date December 6, 2022
News Benzodiazepines Tied to Drug Overdose in Young People With Sleep Disorders Publish Date November 29, 2022
News FDA Moves Toward Making Overdose Antidote an Over-the-Counter Drug Publish Date November 17, 2022
Safety Alerts and Recalls Xylazine-Containing Products Complicate Overdose Management, Warns FDA By Diana Ernst, RPh Publish Date November 8, 2022
News Feds Warn of Home Carbon Monoxide Detectors That May Fail to Alarm Publish Date September 23, 2022
Safety Alerts and Recalls FDA Warns of New Social Media Challenge With OTC Cough, Cold Medications By Brian Park, PharmD Publish Date September 19, 2022
News Three Pharmacy Chains Must Pay $650 Million for Role in Opioid Crisis Publish Date August 19, 2022
News Opioid Tapering Tied to Overdose, Withdrawal, Mental Health Risks for Up to Two Years Publish Date June 30, 2022
News Nalmefene HCl Injection Now Available for Opioid Overdose Treatment By Brian Park, PharmD Publish Date June 22, 2022
News Gabapentin-Involved Overdose Deaths Increased Between 2019 and 2020 By Diana Ernst, RPh Publish Date May 19, 2022